RDY
Price
$15.08
Change
+$0.20 (+1.34%)
Updated
Jul 3 closing price
Capitalization
12.48B
17 days until earnings call
TLPH
Price
$0.45
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
17.48M
Interact to see
Advertisement

RDY vs TLPH

Header iconRDY vs TLPH Comparison
Open Charts RDY vs TLPHBanner chart's image
Dr. Reddy's Laboratories
Price$15.08
Change+$0.20 (+1.34%)
Volume$583.44K
Capitalization12.48B
Talphera
Price$0.45
Change-$0.00 (-0.00%)
Volume$27.2K
Capitalization17.48M
RDY vs TLPH Comparison Chart in %
Loading...
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RDY vs. TLPH commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDY is a Hold and TLPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (RDY: $15.08 vs. TLPH: $0.45)
Brand notoriety: RDY and TLPH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RDY: 36% vs. TLPH: 69%
Market capitalization -- RDY: $12.48B vs. TLPH: $17.48M
RDY [@Pharmaceuticals: Other] is valued at $12.48B. TLPH’s [@Pharmaceuticals: Other] market capitalization is $17.48M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RDY’s FA Score shows that 1 FA rating(s) are green whileTLPH’s FA Score has 0 green FA rating(s).

  • RDY’s FA Score: 1 green, 4 red.
  • TLPH’s FA Score: 0 green, 5 red.
According to our system of comparison, RDY is a better buy in the long-term than TLPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RDY’s TA Score shows that 4 TA indicator(s) are bullish while TLPH’s TA Score has 3 bullish TA indicator(s).

  • RDY’s TA Score: 4 bullish, 5 bearish.
  • TLPH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RDY is a better buy in the short-term than TLPH.

Price Growth

RDY (@Pharmaceuticals: Other) experienced а -1.63% price change this week, while TLPH (@Pharmaceuticals: Other) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

RDY is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDY($12.5B) has a higher market cap than TLPH($17.5M). RDY YTD gains are higher at: -4.497 vs. TLPH (-13.948). RDY has higher annual earnings (EBITDA): 84.9B vs. TLPH (-9.84M). RDY has more cash in the bank: 72.4B vs. TLPH (9.38M). RDY has higher revenues than TLPH: RDY (271B) vs TLPH (651K).
RDYTLPHRDY / TLPH
Capitalization12.5B17.5M71,429%
EBITDA84.9B-9.84M-862,630%
Gain YTD-4.497-13.94832%
P/E Ratio19.68N/A-
Revenue271B651K41,628,264%
Total Cash72.4B9.38M771,773%
Total Debt19.9BN/A-
FUNDAMENTALS RATINGS
RDY vs TLPH: Fundamental Ratings
RDY
TLPH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
32100
SMR RATING
1..100
4898
PRICE GROWTH RATING
1..100
5185
P/E GROWTH RATING
1..100
57100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDY's Valuation (81) in the Pharmaceuticals Generic industry is in the same range as TLPH (96) in the Pharmaceuticals Other industry. This means that RDY’s stock grew similarly to TLPH’s over the last 12 months.

RDY's Profit vs Risk Rating (32) in the Pharmaceuticals Generic industry is significantly better than the same rating for TLPH (100) in the Pharmaceuticals Other industry. This means that RDY’s stock grew significantly faster than TLPH’s over the last 12 months.

RDY's SMR Rating (48) in the Pharmaceuticals Generic industry is somewhat better than the same rating for TLPH (98) in the Pharmaceuticals Other industry. This means that RDY’s stock grew somewhat faster than TLPH’s over the last 12 months.

RDY's Price Growth Rating (51) in the Pharmaceuticals Generic industry is somewhat better than the same rating for TLPH (85) in the Pharmaceuticals Other industry. This means that RDY’s stock grew somewhat faster than TLPH’s over the last 12 months.

RDY's P/E Growth Rating (57) in the Pharmaceuticals Generic industry is somewhat better than the same rating for TLPH (100) in the Pharmaceuticals Other industry. This means that RDY’s stock grew somewhat faster than TLPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RDYTLPH
RSI
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
51%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
46%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
51%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
51%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
39%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
42%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QGRO109.091.37
+1.27%
American Century US Quality Growth ETF
TWN45.630.12
+0.26%
Taiwan Fund
GLNK19.800.03
+0.16%
Grayscale Chainlink Trust (LINK)
IWFG49.25N/A
N/A
NYLI Winslow Focused Large Cap Gr ETF
PFFR18.03-0.01
-0.03%
InfraCap REIT Preferred ETF

RDY and

Correlation & Price change

A.I.dvisor tells us that RDY and COLL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and COLL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+1.34%
COLL - RDY
31%
Poorly correlated
-0.52%
KMDA - RDY
28%
Poorly correlated
+1.81%
AMPH - RDY
26%
Poorly correlated
-1.61%
OGI - RDY
26%
Poorly correlated
+3.62%
HROW - RDY
25%
Poorly correlated
+3.86%
More

TLPH and

Correlation & Price change

A.I.dvisor tells us that TLPH and LVZPF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and LVZPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPH
1D Price
Change %
TLPH100%
N/A
LVZPF - TLPH
31%
Poorly correlated
N/A
TXMD - TLPH
23%
Poorly correlated
+3.51%
OPTN - TLPH
23%
Poorly correlated
N/A
RDY - TLPH
22%
Poorly correlated
+1.34%
HROW - TLPH
22%
Poorly correlated
+3.86%
More